Neurocrine Biosciences (0K6R.L) Stock Price
$139.9 0.4%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
8 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Neurocrine Biosciences, AI stock picks, stock alerts and much more.
0K6R.L AI Stock Analysis
Financial Performance
Neurocrine Biosciences' financial performance shows some concerns. The company's revenue, gross profit, and operating income have all seen a decrease both quarter over quarter and year over year. This indicates the company may be facing challenges in maintaining its profitability. The EBITDA ratio of 0.04 also suggests that the company's earnings before interest, taxes, depreciation, and amortization are low.
Stock Price
The stock price has shown positive growth with an increase of 6.8% in the last month and 17.1% year over year despite the negative financial indicators. The RSI value is currently at 63.87 which typically suggests it may be becoming overbought and could see a price correction soon. However, with the stock trading above its 200-day moving average this generally indicates an upward trend in price.
Alternative Data Signals
The website traffic for Neurocrine Biosciences has decreased by -11.9%, which might indicate lessening public interest or engagement with the company online but this is not definitive proof of performance decline as many factors can influence web traffic numbers.The number of job postings has increased suggesting potential expansion or turnover within the company while employee outlook has been reported as positive but declining from previous periods.The social media following on Twitter and Facebook shows significant growth indicating potentially increasing brand awareness or consumer engagement.
Conclusion
In conclusion, Neurocrine Biosciences' stock presents a mixed picture based on the analyzed data points.While there are positive signs in terms of stock price increase and growing social media following,the declining financials signal potential issues that could impact future performance.Therefore,the analysis is neutral towards Neurocrine Biosciences' stock.
Note: This AI Stock Analysis is based on data as of September 13. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Neurocrine Biosciences (0K6R.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $139.9, will... Sign up to access price prediction.
About 0K6R.L
-
Neurocrine Biosciences, Inc.
-
Symbol
0K6R.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
13.9B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$392.1 0.5% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$7.87 1.6% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.62 2.4% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.76 0.8% |
6 |
 |
Thermo Fisher Scientific Inc. 0R0H.L |
$480.3 0.4% |
6 |
News
0K6R.L Alternative Data
Web Traffic
Neurocrine Biosciences receives an estimated 33666 monthly visitors to neurocrine.com.
-
Web Traffic
33666
-
Change from Previous Month
11.9%
-
3 Month Change
28.6%
-
YoY Change
28.6%
Twitter Followers
Neurocrine Biosciences has 801 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.2% over the last month.
-
Twitter Followers
801
-
Daily Change
0.3%
-
1 Month Change
2.2%
-
3 Month Change
6.1%
-
YoY Change
6.1%
Facebook Engagement
Neurocrine Biosciences has engaged 51 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
51
-
Daily Change
21.5%
-
1 Month Change
466.7%
-
3 Month Change
240%
-
YoY Change
240%
Job Postings
Neurocrine Biosciences currenly has an estimated 82 open job postings, up by 13.9% over the last month.
-
Job Postings
82
-
Daily Change
3.8%
-
1 Month Change
13.9%
-
3 Month Change
7.9%
-
YoY Change
7.9%
Reddit Mentions
Neurocrine Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
79,591 are following Neurocrine Biosciences on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
79591
-
Daily Change
1.8%
-
1 Month Change
1.8%
-
3 Month Change
6.6%
-
YoY Change
6.6%
LinkedIn Employees
According to LinkedIn, Neurocrine Biosciences has 1,998 employees, up by 0.7% over the last month.
-
LinkedIn Employees
1998
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
3.5%
-
YoY Change
3.5%
Business Outlook
According to employee reviews, the business outlook among employees at Neurocrine Biosciences is 75 out of 100 (bullish).
-
Business Outlook
75
-
Change from Previous Month
8.5%
-
3 Month Change
9.6%
-
YoY Change
9.6%
News Mentions
Neurocrine Biosciences was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0K6R.L Financials
0K6R.L Key Metrics
-
Total Revenue
$572.6M
-
Net Income
$7.9M
-
Earnings per Share
$0.08
-
Free cash flow
$54.1M
-
EBITDA
$23.6M
-
EBITDA Ratio
0.0412155
-
Total Assets
$3.7B
0K6R.L 2-year Revenue & Income
0K6R.L 2-year Free Cash Flow
0K6R.L Technicals
0K6R.L SMA
0K6R.L RSI
FAQ
What's the current price of Neurocrine Biosciences (0K6R.L) Stock?
The price of an Neurocrine Biosciences (0K6R.L) share is $139.9.
What's the market cap of Neurocrine Biosciences?
The current market cap of Neurocrine Biosciences is 13.9B.
What are some stocks similar to Neurocrine Biosciences (0K6R.L) that investors often compare it to?
Neurocrine Biosciences (0K6R.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Emergent BioSolutions Inc., Abeona Therapeutics Inc., Esperion Therapeutics and Thermo Fisher Scientific Inc..
What is the forecast for Neurocrine Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Neurocrine Biosciences' stock price to be around $145.5 in 2026. Starting from the current price of $139.9, this represents a 4% change in price, indicating a neutral outlook for the stock.
How to buy Neurocrine Biosciences (0K6R.L) Stock?
Neurocrine Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Neurocrine Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.